Avidity Biosciences, Inc. (RNAM)
Latest RNAM Insider Trades
About Avidity Biosciences, Inc. (RNAM)
The SEC lists Avidity Biosciences, Inc. under CIK 0001599901, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
90-Day SEC Filing Activity
No Form 4 activity for RNAM in the last 90 days.
RNAM Insider Transactions (Form 4)
9459 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Troy Edward Wilson - Director | Option exercise | Common Stock | 14,500 |
Recent RNAM Form 8-K Filings
3RNAM Insider Trading - FAQ
What is the latest insider trade for RNAM?
Avidity Biosciences, Inc. (RNAM) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-27. The full record for RNAM runs to 59 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RNAM stock?
No insider purchases of RNAM were filed in the last 90 days.
How many insiders are selling RNAM stock?
No insider sales of RNAM were filed in the last 90 days. 58 sales are on record for this company.
Where can I see RNAM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks RNAM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RNAM insider buys?
Create a free InsiderAlpha account and press Watch on this page to add RNAM to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Teresa McCarthy view on EDGAR
- - Tamar Thompson view on EDGAR
- - Michael F. Maclean view on EDGAR
- - Simona Skerjanec view on EDGAR
- - Steven George Hughes view on EDGAR
- - Sarah Boyce view on EDGAR
- - John B. Moriarty view on EDGAR
- - W. Michael Flanagan view on EDGAR
- - Troy Edward Wilson view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where RNAM's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track RNAM insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
